Persistent Expression of CD26/DPPIV After Treatment with Infliximab in Psoriasis Despite Clinical Improvement
Rosanne G. van Lingen, Piet E.J. van Erp, Marieke M.B. Seyger, Elke M.G.J. de Jong, Roelie T. de Boer-van Huizen, Rieke JB Driessen, Peter C.M. van de Kerkhof
DOI: 10.2340/00015555-0675
Abstract
This article does not have an abstract.
Significance
Supplementary content
Comments
